Header Logo

Connection

Zoe Arvanitakis to Alzheimer Disease

This is a "connection" page, showing publications Zoe Arvanitakis has written about Alzheimer Disease.
Connection Strength

5.549
  1. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.414
  2. Insulin resistance, cognition, and Alzheimer disease. Obesity (Silver Spring). 2023 06; 31(6):1486-1498.
    View in: PubMed
    Score: 0.403
  3. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease. J Alzheimers Dis. 2023; 93(3):1135-1151.
    View in: PubMed
    Score: 0.392
  4. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020 09; 88(3):513-525.
    View in: PubMed
    Score: 0.331
  5. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.318
  6. Author response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2019 04 09; 92(15):732.
    View in: PubMed
    Score: 0.302
  7. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
    View in: PubMed
    Score: 0.287
  8. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.258
  9. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.249
  10. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.242
  11. Clinical trial efforts in Alzheimer disease: why test statins? Neurology. 2010 Mar 23; 74(12):945-6.
    View in: PubMed
    Score: 0.161
  12. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.143
  13. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
    View in: PubMed
    Score: 0.139
  14. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006 Dec 12; 67(11):1960-5.
    View in: PubMed
    Score: 0.129
  15. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.115
  16. Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. Mol Neurodegener. 2025 02 04; 20(1):15.
    View in: PubMed
    Score: 0.113
  17. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004 May; 61(5):661-6.
    View in: PubMed
    Score: 0.107
  18. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther. 2022 10 11; 14(1):152.
    View in: PubMed
    Score: 0.096
  19. APOE e4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med. 2023 Jan-Mar; 71(1):103362.
    View in: PubMed
    Score: 0.095
  20. Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord. 2002 Jul-Sep; 16(3):187-90.
    View in: PubMed
    Score: 0.095
  21. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.094
  22. Diagnosis and Management of Dementia: Review. JAMA. 2019 10 22; 322(16):1589-1599.
    View in: PubMed
    Score: 0.078
  23. Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019 01; 15(1):158-167.
    View in: PubMed
    Score: 0.074
  24. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.073
  25. Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol. 2018 06; 44(4):347-362.
    View in: PubMed
    Score: 0.070
  26. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.065
  27. Diabetes is Not Associated with Alzheimer's Disease Neuropathology. J Alzheimers Dis. 2017; 60(3):1035-1043.
    View in: PubMed
    Score: 0.065
  28. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.058
  29. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 2014 Nov; 128(5):679-89.
    View in: PubMed
    Score: 0.055
  30. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. Parkinsonism Relat Disord. 2013 Feb; 19(2):227-31.
    View in: PubMed
    Score: 0.049
  31. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.048
  32. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.047
  33. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.046
  34. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.043
  35. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.039
  36. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.038
  37. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.033
  38. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007 May; 66(5):389-98.
    View in: PubMed
    Score: 0.033
  39. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.032
  40. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 Jun 27; 66(12):1837-44.
    View in: PubMed
    Score: 0.031
  41. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.030
  42. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.021
  43. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.015
  44. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.015
  45. Dementia with Lewy bodies: current concepts. Dement Geriatr Cogn Disord. 2005; 20(5):306-20.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.